Drug Pipeline

TTRNA-xALT Clinical Trials

Name: TTRNA-xALT clinical trials — 3 active studies
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12

Active Studies

Recruiting

Top Sponsors

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-06-11	NCT06514898 Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune…	overall status: "Active Not Recruiting" → "Recruiting"
2026-05-28	NCT06254326 ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG)…	overall status: "Active Not Recruiting" → "Recruiting"

Active Studies by Phase

Phase 1

Active Trials

NCT ID	Title	Condition	Status
Phase 1
NCT06254326	ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG)…	Recurrent Oligodendroglioma	Recruiting
NCT06514898	Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune…	Recurrent Group 3 Medulloblastoma	Recruiting
NCT04837547	PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy	Neuroblastoma	Active, Not Recruiting

Sponsors Running TTRNA-xALT Trials

University of Florida (3)

Disease Areas

Glioma (2)

Get alerts when TTRNA-xALT trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.